Geode Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Sell |
|
|||||
|
2025
Q1 | $373K | Buy |
|
|||||
|
2024
Q4 | $942K | Buy |
|
|||||
|
2024
Q3 | $1.13M | Buy |
|
|||||
|
2024
Q2 | $1.14M | Sell |
|
|||||
|
2024
Q1 | $3.81M | Buy |
|
|||||
|
2023
Q4 | $2.06M | Buy |
|
|||||
|
2023
Q3 | $3.07M | Buy |
|
|||||
|
2023
Q2 | $3.83M | Buy |
|
|||||
|
2023
Q1 | $6.89M | Buy |
|
|||||
|
2022
Q4 | $4.68M | Buy |
|
|||||
|
2022
Q3 | $7.26M | Buy |
|
|||||
|
2022
Q2 | $5.98M | Sell |
|
|||||
|
2022
Q1 | $9.86M | Sell |
|
|||||
|
2021
Q4 | $9.28M | Buy |
|
|||||
|
2021
Q3 | $8.19M | Buy |
|
|||||
|
2021
Q2 | $12.3M | Buy |
|
|||||
|
2021
Q1 | $12.1M | Buy |
|
|||||
|
2020
Q4 | $16.1M | Sell |
|
|||||
|
2020
Q3 | $15.4M | Buy |
|
|||||
|
2020
Q2 | $19.6M | Buy |
|
|||||
|
2020
Q1 | $17.9M | Buy |
|
|||||
|
2019
Q4 | $15.9M | Buy |
|
|||||
|
2019
Q3 | $7.58M | Buy |
|
|||||
|
2019
Q2 | $4.62M | Buy |
|
|||||
|
2019
Q1 | $3.43M | Buy |
|
|||||
|
2018
Q4 | $5.23M | Buy |
|
|||||
|
2018
Q3 | $9.05M | Buy |
|
|||||
|
2018
Q2 | $8.76M | Buy |
|
|||||
|
2018
Q1 | $4.31M | Buy |
|
|||||
|
2017
Q4 | $2.69M | Buy |
|
|||||
|
2017
Q3 | $2.91M | Buy |
|
|||||
|
2017
Q2 | $2.36M | Buy |
|
|||||
|
2017
Q1 | $2.17M | Buy |
|
|||||
|
2016
Q4 | $1.47M | Buy |
|
|||||
|
2016
Q3 | $1.43M | Buy |
|
|||||
|
2016
Q2 | $962K | Buy |
|
|||||
|
2016
Q1 | $1.24K | Buy |
|
|||||
|
2015
Q4 | $1.84M | Buy |
|
|||||
|
2015
Q3 | $1.43M | Buy |
|
|||||
|
2015
Q2 | $3.59M | Buy |
|
|||||
|
2015
Q1 | $3.77M | Buy |
|
|||||
|
2014
Q4 | $2.89M | Sell |
|
|||||
|
2014
Q3 | $2.71M | Buy |
|
|||||
|
2014
Q2 | $2.24M | Buy |
|
|||||
|
2014
Q1 | $1.38M | Buy |
|
|||||
|
2013
Q4 | $812K | Buy |
|